Myo - Myomo, Inc.

Discussion in 'Investment Charts' started by fireopal, Jan 3, 2018.

  1. fireopal

    fireopal Senior Investor

    Joined:
    Jan 2017
    Posts:
    128
    Likes Received:
    5
    [​IMG]
    Myomo, Inc., a commercial stage medical robotics Company, provides expanded mobility solutions for patients suffering from neurological disorders and upper limb paralysis in the United States. The company develops and markets MyoPro, a myoelectric elbow/wrist/hand orthosis that supports an impaired hands and arms of individuals due to a brachial plexus injury, stroke, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, and other upper limb neuromuscular deficits. Myomo, Inc. and is headquartered in Cambridge, Massachusetts.

    Company website - http://www.myomo.com
    O/S = 11.1M
    float = 3.37 M
     
  2. fireopal

    fireopal Senior Investor

    Joined:
    Jan 2017
    Posts:
    128
    Likes Received:
    5
    This was a delayed IPO play that made a pretty nice move before heading down - had a nice run up to $11's not too long ago & i expect more to come!!
     
  3. Chartman

    Chartman Senior Investor

    Joined:
    Sep 2017
    Posts:
    149
    Likes Received:
    2
    Seems to be edging higher which is a better pattern than volatility - at least in my book :)
     
  4. gowiththeflow

    gowiththeflow Senior Investor

    Joined:
    Jul 2017
    Posts:
    242
    Likes Received:
    4
    Stock is only a fraction of its original float price - robotics/artificial limbs are a huge market!

    What do the profit forecasts looks like for the short to medium term?
     
  5. Chartman

    Chartman Senior Investor

    Joined:
    Sep 2017
    Posts:
    149
    Likes Received:
    2
    If this company shows any signs of returning to its former glories prior to the flotation, my guess is it would be picked up by a larger conglomerate or competitor. There are some stocks which are unsuitable for stock market flotations purely and simply because investors and analysts do not always understand them. This type of robotic assistance technology must take years to develop and even longer to monetise.
     

Share This Page